British American Tobacco Given Buy Rating at Panmure Gordon (BATS)
British American Tobacco (LON:BATS)‘s stock had its “buy” rating reiterated by analysts at Panmure Gordon in a research report issued to clients and investors on Wednesday, StockRatingsNetwork reports. They currently have a GBX 3,900 ($62.57) price objective on the stock. Panmure Gordon’s price objective indicates a potential upside of 21.42% from the stock’s previous close.
Shares of British American Tobacco (LON:BATS) traded down 0.19% during mid-day trading on Wednesday, hitting GBX 3206.0002. The stock had a trading volume of 1,438,396 shares. British American Tobacco has a 52-week low of GBX 3060.50 and a 52-week high of GBX 3807.50. The stock’s 50-day moving average is GBX 3365. and its 200-day moving average is GBX 3500.. The company’s market cap is £61.139 billion.
Several other analysts have also recently commented on the stock. Analysts at Citigroup Inc. reiterated a “buy” rating on shares of British American Tobacco in a research note to investors on Friday, October 4th. They now have a GBX 3,800 ($60.97) price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of British American Tobacco in a research note to investors on Thursday, October 3rd. They now have a GBX 4,549 ($72.98) price target on the stock. Finally, analysts at Canaccord Genuity reiterated a “sell” rating on shares of British American Tobacco in a research note to investors on Wednesday, October 2nd. They now have a GBX 3,000 ($48.13) price target on the stock. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and eighteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of GBX 3,786.58 ($60.75).
British American Tobacco p.l.c. (LON:BATS) is a holding company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.